VersaBank is a federally regulated North American bank that operates a cloud-based, largely branchless business-to-business model. It raises deposits and extends credit mainly through financial intermediary partners rather than a traditional retail branch network, targeting underserved specialty lending niches such as point-of-sale receivable financing. The model aims for high operating leverage and risk mitigation by digitizing partner-sourced funding and lending across Canada and the United States.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 30.1 | — | 8.5 | -1.1% |
| Q3 2025 | 31.6 | — | 6.6 | -6.1% |
| Q4 2025 | 35.1 | — | 5.2 | 43.2% |
| Q1 2026 | 36.5 | — | 11.1 | 77.8% |
| Q2 2026 | 38.3 | 27.1% | 7.5 | -11.8% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Cytek Biosciences, Inc. (CTKB), Crescent Biopharma, Inc. (CBIO), ASP Isotopes Inc. (ASPI), The Honest Company, Inc. (HNST), Contineum Therapeutics, Inc. (CTNM), NioCorp Developments Ltd. (NB)